Free Trial

XOMA (XOMAO) Competitors

XOMA logo
$25.06 -0.10 (-0.42%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

XOMAO vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying XOMA stock or one of its competitors? The main competitors of XOMA include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

XOMA vs.

XOMA (NASDAQ:XOMAO) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, XOMA had 5 more articles in the media than 180 Life Sciences. MarketBeat recorded 5 mentions for XOMA and 0 mentions for 180 Life Sciences. XOMA's average media sentiment score of 0.47 beat 180 Life Sciences' score of 0.00 indicating that XOMA is being referred to more favorably in the media.

Company Overall Sentiment
XOMA Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$10.22MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

XOMA and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
XOMAN/AN/A
180 Life SciencesN/AN/A

Summary

XOMA beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XOMAO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAO vs. The Competition

MetricXOMABiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$121.10M$5.31B$7.35B
Dividend Yield9.00%3.75%5.45%4.31%
P/E RatioN/A3.0521.9417.82
Price / SalesN/A4,230.36380.9497.68
Price / CashN/A13.1938.2634.64
Price / BookN/A34.276.453.98
Net IncomeN/A-$91.73M$3.22B$247.81M
7 Day Performance0.47%2.14%5.85%3.19%
1 Month Performance-0.77%-5.23%-9.55%-7.70%
1 Year Performance0.36%84.68%11.83%1.49%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAO
XOMA
N/A$25.18
+0.0%
N/A+0.4%$0.00$10.22M0.0010Short Interest ↓
News Coverage
ATNFW
180 Life Sciences
N/A$0.01
+1.4%
N/A-12.2%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+1.3%
N/A-80.5%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.06
-43.2%
N/A+97.8%$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.07
flat
N/A-68.4%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+1.8%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.06
-7.7%
N/AN/A$0.00$37.32M0.0070
BTMDW
biote
N/A$0.06
flat
N/AN/A$0.00$197.19M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.09
-10.1%
N/A-93.1%$0.00N/A0.008Gap Down
High Trading Volume
CELUW
Celularity
N/A$0.04
flat
N/A+1.0%$0.00$48.20M0.00220Gap Down

Related Companies and Tools


This page (NASDAQ:XOMAO) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners